Zobrazeno 1 - 10
of 392
pro vyhledávání: '"Angel, Guerrero"'
Autor:
Rodrigo Lozano-Corona, Adriana Torres-Machorro, Reinhard Ortiz-Beitz, Aristeo Reyes-Monroy, Ignacio García-Lugo, Christopher Ruben-Castillo, Luis Angel Guerrero-Galindo
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-10 (2023)
Abstract Trauma is the leading cause of death in the pediatric population. Although vascular trauma has an incidence of 6% in civilian population, iatrogenic injuries are the leading cause, and the most frequent injured vessel is the iliofemoral sect
Externí odkaz:
https://doaj.org/article/63f1cc1aa4f24ffe815c59e7ae6d436a
Autor:
Holmes, Frankie A., Moy, Beverly, Delaloge, Suzette, Chia, Stephen K.L., Ejlertsen, Bent, Mansi, Janine, Iwata, Hiroji, Gnant, Michael, Buyse, Marc, Barrios, Carlos H., Silovski, Tajana, Šeparović, Robert, Bashford, Anna, Zotano, Angel Guerrero, Denduluri, Neelima, Patt, Debra, Gokmen, Erhan, Gore, Ira, Smith, John W., II, Loibl, Sibylle, Masuda, Norikazu, Tomašević, Zorica, Petráková, Katarina, DiPrimeo, Daniel, Wong, Alvin, Martin, Miguel, Chan, Arlene
Publikováno v:
In European Journal of Cancer May 2023 184:48-59
Autor:
Angel Guerrero, Gadi V. P. Reddy
Publikováno v:
Insects, Vol 14, Iss 10, p 799 (2023)
Chemical communication plays a pivotal role in many insect behaviors, including food-seeking, recruitment, the recognition of congeners, reproduction, alarm, territorial marking, and survival [...]
Externí odkaz:
https://doaj.org/article/5febdbe416124587a510d2d8eb5ec586
Autor:
Andres Poveda, Ana Oaknin, Ignacio Romero, Angel Guerrero-Zotano, Lorena Fariñas-Madrid, Victor Rodriguez-Freixinos, Pedro Mallol, Raquel Lopez-Reig, Jose Antonio Lopez-Guerrero
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib has shown antitumor activity in patients with ovarian or breast cancer with or without BRCA1/2 mutations. Lurbinectedin is an ecteinascidin that generates DNA double-strand breaks. W
Externí odkaz:
https://doaj.org/article/d1515ed3222c482292aa0ffa3a73aad2
Autor:
Franklin Parrales Bravo, Alberto A. Del Barrio Garcia, Ana Beatriz Gago Veiga, Maria Mercedes Gallego De La Sacristana, Marina Ruiz Pinero, Angel Guerrero Peral, Saso Dzeroski, Jose L. Ayala
Publikováno v:
IEEE Access, Vol 7, Pp 92598-92614 (2019)
Deciding on the continuous treatment of chronic diseases is vital in terms of economy, quality of life, and time. We present a holistic data mining approach that addresses the prediction of the therapeutic response in a panoramic and feedback way whi
Externí odkaz:
https://doaj.org/article/f1d8fcb2893b419295782aae8e842a6e
Autor:
Frankie A. Holmes, Beverly Moy, Suzette Delaloge, Stephen K.L. Chia, Bent Ejlertsen, Janine Mansi, Hiroji Iwata, Michael Gnant, Marc Buyse, Carlos H. Barrios, Tajana Silovski, Robert Šeparović, Anna Bashford, Angel Guerrero Zotano, Neelima Denduluri, Debra Patt, Erhan Gokmen, Ira Gore, John W. Smith, Sibylle Loibl, Norikazu Masuda, Zorica Tomašević, Katarina Petráková, Daniel DiPrimeo, Alvin Wong, Miguel Martin, Arlene Chan
Publikováno v:
European Journal of Cancer. 184:48-59
ExteNET showed that neratinib, an irreversible pan-HER tyrosine ki- nase inhibitor, given for 1 year after trastuzumab-based therapy significantly improved inva- sive disease-free survival in women with early-stage HER2-positive breast cancer. We rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f52b3f56c3541c7f92ad50e9e346cad
https://doi.org/10.1016/j.ejca.2023.02.002
https://doi.org/10.1016/j.ejca.2023.02.002
Publikováno v:
In Archives of Civil and Mechanical Engineering September 2018 18(4):1219-1227
Autor:
Bernard X.W. Liew, María Palacios-Ceña, Marco Scutari, Stella Fuensalida-Novo, Angel Guerrero-Peral, Carlos Ordás-Bandera, Juan A. Pareja, César Fernández-de-las-Peñas
Publikováno v:
The Journal of Pain. 24:426-436
Tension type headache (TTH) is a prevalent but poorly understood pain disease. Current understanding supports the presence of multiple associations underlying its pathogenesis. Our aim was to compare competing multivariate pathway models that explain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbedcda035837cabbb4519d508871b2f
https://doi.org/10.1016/j.jpain.2022.10.003
https://doi.org/10.1016/j.jpain.2022.10.003
Autor:
Silvia Antolin Novoa, César A Rodríguez, Josefina Cruz, Sara López-Tarruella, Ariadna Tibau, Encarna Adrover, Ana Miguel, Mireia Margelí, Purificación Martínez, María Hernández, Antonio Antón, Álvaro Rodríguez-Lescure, Catalina Falo, Isabel Álvarez, Diego Malón, Raquel Andrés, José L Alonso-Romero, César Gómez, J. José Illaramendi, Ruth Campo, Juan José Miralles, Susana Bezares, Federico Rojo, Angel Guerrero-Zotano
Publikováno v:
Cancer Research. 83:P4-07
Background: Triple negative breast cancer (TNBC) is well known for its more aggressive course and poorer prognosis compared to other BC subtypes. RegistEM study provides real world data to understand the distribution of BC subtypes in the advanced se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd263d24bc1ba75ed50aca54c245b128
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-45
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-45
Autor:
Isabel Álvarez, Angel Guerrero-Zotano, Ariadna Tibau, Catalina Falo, María Hernández, Ana Miguel, Raquel Andrés, Álvaro Rodríguez-Lescure, Miguel Corbellas, Sara López-Tarruella, Purificación Martínez, Cesar A Rodríguez, Diego Malón, María Marin, Mª José Echarri, Antonio Antón, Josefina Cruz, Diana Moreno, J. Ignacio Chacón, Ruth Campo, Andrea Blasco, Susana Bezares, Federico Rojo, Silvia Antolin
Publikováno v:
Cancer Research. 83:P4-07
Background: HER2-low breast cancer (BC) is a new therapeutic entity, but it is uncertain if this subgroup of BC differs from HER2-negative tumors in clinical characteristics, prognosis, and response to therapy. The objective is to describe the clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a0bce9786ce02386dbba6e66063c87
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-30
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-30